Dimopoulos, M. A., & Goldschmidt, H. (2015). Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone. Haematologica, 100(10), . https://doi.org/10.3324/haematol.2014.117077
Chicago Style (17th ed.) CitationDimopoulos, Meletios A., and Hartmut Goldschmidt. "Cytogenetics and Long-term Survival of Patients with Refractory or Relapsed and Refractory Multiple Myeloma Treated with Pomalidomide and Low-dose Dexamethasone." Haematologica 100, no. 10 (2015). https://doi.org/10.3324/haematol.2014.117077.
MLA (9th ed.) CitationDimopoulos, Meletios A., and Hartmut Goldschmidt. "Cytogenetics and Long-term Survival of Patients with Refractory or Relapsed and Refractory Multiple Myeloma Treated with Pomalidomide and Low-dose Dexamethasone." Haematologica, vol. 100, no. 10, 2015, https://doi.org/10.3324/haematol.2014.117077.